Investigating the effect of vitamin B1 oral tablets on the post covid-19 syndrome

Not Applicable

• Conditions: Post covid-19 syndrome.; U07.1; COVID-19, virus identified

• Registration Number: IRCT20221229056979N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

All Patients who have recovered from covid 19 but after three weeks the symptoms of post covid 19 syndrome remain

Exclusion Criteria

Pregnancy
Immune deficiency patients
Patients who use antipsychotic drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep quality. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire.;Hair loss. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire.;Skin rashes. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire.;Dyspnea. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Quality of life score. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire.